HOME >> MEDICINE >> NEWS
Soldiers acquired drug-resistant infections in field hospitals

An outbreak of drug-resistant wound infections among soldiers in Iraq likely came from the hospitals where they were treated, not the battlefield, according to a new study in the June 15 issue of Clinical Infectious Diseases, currently available online.

The outbreak of drug-resistant Acinetobacter baumannii-calcoaceticus complex (ABC) infections among U.S. service members injured in Iraq has been of major concern to military health care workers since it was first detected in 2003. ABC bacteria are commonly found in soil and water. They sometimes also exist on the skin of healthy people. The bacteria pose little risk to healthy people. However, those with open wounds or weakened immune systems are at greater risk of ABC infection. An ABC infection can cause or contribute to death, especially if the patient is immunosuppressed.

Historically, ABC infections were treated with a wide variety of drugs. Unfortunately, in recent years, strains of Acinetobacter have been emerging that are resistant to nearly all known remedies. The ABC infections found among the U.S. service members are of this type, known as multi-drug resistant (MDR).

Between March and October 2003, researchers from the Army and the Centers for Disease Control and Prevention identified 145 inpatients at U.S. military treatment facilities infected or colonized with ABC. The researchers attempted to identify the source(s) of the outbreak. They tested for the presence of ABC on the skin of casualties treated in or evacuated from Iraq. They tested soil samples taken near field hospitals in Iraq and from locations throughout Iraq and Kuwait. And they looked at samples taken from in and around patient-treatment areas in five field hospitals in Iraq and two in Kuwait.

They found ABC in only one out of 49 soil samples and just one out of 160 samples from soldiers skin. By contrast, ABC organisms were found in the patient treatment areas of all seven field hospitals sampl
'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
21-May-2007


Page: 1 2

Related medicine news :

1. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
2. Hospital-acquired infections -- Inevitable?
3. Study indicates dramatic rise in antibiotic-resistant community-acquired staph infections
4. Scientists uncover genes for virulence in strain of community-acquired MRSA
5. PlasmaSol, Stevens spin-out, acquired for $17.5 million
6. Heart burn medication a risk factor for community-acquired C. difficile
7. Chest x-rays not effective in determining when TB acquired
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. US soldiers in Iraq fighting drug-resistant bacteria after injuries
10. Wrapping Gleevec fights drug-resistant cancer
11. New research may overturn conventional wisdom on drug-resistant tuberculosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... Dr. Barry ... Avenue Cosmetic Plastic Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic ... of the newest techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... ("GPP") portfolio company, today announced it has acquired the assets of Frankfurt, ... previously a subsidiary of Chiltern International and focuses on clinical trial drug ...
(Date:12/5/2016)... ... ... has joined the Retina Group of New York (RGONY) specializing in uveitis and ... and has been providing tertiary medical and surgical retinal care on Long Island for over ... peers. Growing up in a family of doctors, Dr. Shah emulated the role of ...
(Date:12/5/2016)... ... December 05, 2016 , ... Houston ... 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine European ... European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, clinicians, ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Swirl: A Wine Tasting Event in New York City, with long-time partners The ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Several leading Alzheimer,s disease experts will participate in ... 11 a.m. EST on December 6 in advance of ... Alzheimer,s Disease (CTAD). The program will include discussions on ... targets that address deficient glucose metabolism observed in Alzheimer,s ... another therapy targeting the amyloid hypothesis, now more than ...
(Date:12/5/2016)... and BOCA RATON, Fla. ... Florida Institute for the Commercialization of Public Research ... has finalized a funding agreement SegAna, LLC, an ... developed at University of Central Florida. The Florida ... research, and bridges early funding gaps for companies ...
(Date:12/5/2016)... , December 5, 2016 According to a ... modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), Application ... MarketsandMarkets, the market is projected to reach USD 779.8 Million by ... of 13.5% during the forecast period of 2016 to 2021. ... ...
Breaking Medicine Technology:
Cached News: